Is GLYDA 5 TABLETS (Each tablet contains Dapagliflozin 5mg) registered in Ghana?

GLYDA 5 TABLETS (Each tablet contains Dapagliflozin 5mg) is recorded with registration status “Valid” in Ghana, registration number FDA/SD.263-030356, based on FDA Ghana data.

Who manufactures GLYDA 5 TABLETS (Each tablet contains Dapagliflozin 5mg)?

GLYDA 5 TABLETS (Each tablet contains Dapagliflozin 5mg) is manufactured by Hetero Labs.

What is the active ingredient in GLYDA 5 TABLETS (Each tablet contains Dapagliflozin 5mg)?

GLYDA 5 TABLETS (Each tablet contains Dapagliflozin 5mg) contains (Each tablet contains Dapagliflozin 5mg), dosage form (Each tablet contains Dapagliflozin 5mg).

Valid Ghana · FDA Ghana

GLYDA 5 TABLETS (Each tablet contains Dapagliflozin 5mg)

(Each tablet contains Dapagliflozin 5mg)

FDA/SD.263-030356 (Each tablet contains Dapagliflozin 5mg) 5mg

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.

FDA/SD.263-030356

Registration date

2026-03-25

Expiry date

2030-04-01

Status

Valid

Active ingredient

(Each tablet contains Dapagliflozin 5mg)

Dosage form

(Each tablet contains Dapagliflozin 5mg)

Strength

5mg

Pack size

Therapeutic class

Manufacturer / MAH

Hetero Labs

Applicant / LTR

BB Associates Limited, P.O. BOX WJ 360, Weija, Accra, Ghana

Country of origin

Manufacturer location

GCMM+7W2, Saibaba Nagar, Suraram, Hyderabad, Telangana 500055, India

Source: Food and Drugs Authority · fetched 2026-05-22 02:34:52 · updated 2026-10-20 04:00:10

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.